Short interest in Akari Therapeutics PLC (NASDAQ:AKTX) decreased during the last reporting period, falling from 127.36K to 126.75K. This put 0.53% of the company's publicly available shares short.

Short interest for Akari Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Akari Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 20.62K shares traded per day, it would take 6.15 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.